• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of New Treatments for Addiction

New Treatments for Addiction

Behavioral, Ethical, Legal, and Social Questions

Edited by Henrick J Harwood and Tracy G Myers. .

Washington (DC): National Academies Press (US); .
ISBN-10: 0-309-09128-4

Excerpt

This report is the work of the Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction. The committee was established in 2002 by the National Academies in response to a request from the National Institute on Drug Abuse (NIDA). NIDA is funding the development of new types of medications to treat drug addiction and sought the advice of the National Research Council and Institute of Medicine about the behavioral, ethical, legal, and social issues likely to arise as a result of the unique characteristics of these medications, if and when they become available.

The charge to the committee was to identify issues that will be raised in determining who should be given these medications and under what circumstances, given the fundamental issue of therapeutic safety. This study was not intended to be a safety review of immunotherapies and sustained-release formulations, which are still under development. However, safety formed a necessary backdrop for all of the issues the committee considered.

Contents

The study was supported by Contract No. N01-OD-4-2139 between the National Academy of Sciences and the National Institute on Drug Abuse. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.

Suggested citation:

National Research Council and Institute of Medicine. (2004). New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions. Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction. Henrick J. Harwood and Tracy G. Myers, Eds. Board on Behavioral, Cognitive, and Sensory Sciences, Division of Behavioral and Social Sciences and Education, National Research Council; and Board on Health Promotion and Disease Prevention, Board on Neuroscience and Behavioral Health, Institute of Medicine. Washington, DC: The National Academies Press.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

Copyright © 2004, National Academy of Sciences.
Bookshelf ID: NBK24638PMID: 20669471
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (6.7M)

Related information

Related citations in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...